From this: ''In an interview with Scripps News on Wednesday, Kennedy said that cancer vaccines rooted in mRNA ''may be very effective.'' The comments echo similar ones made by NIH Director Jay Bhattacharya in the Washington Post on Tuesday, where he called mRNA vaccines for cancer ''promising.'' HHS is continuing to invest in ongoing research on mRNA applications in cancer and other complex diseases, agency spokesperson Andrew Nixon said in a statement to Endpoints News.'' https://endpoints.news/while-decrying-mrna-for-covid-kennedy-says-he-supports-mrna-in-oncology/
Dr. Vinay Prasad is the director of the FDA's CBER. In 2018, he said: ''As a general rule, when you see endpoint switching, when you see delays in reporting results, when you see a company declining to unblind a study after the sufficient progression-free survival events are reached, and when you hear talk of taking a randomized trial and making a historical comparison — it is hard not to reach the conclusion that a product is more than likely an abject failure, the data are negative, and these efforts are merely a desperate attempt to salvage something.'' https://www.statnews.com/2018/02/15/northwest-bio-clinical-trial/